I should of said FDA approval instead of phase 2. It is mentioned in the investor presentation on page 7 where it outlines the potential to monetise on its products before achieving FDA approval. On the same page it has a graph which references many recent dermatology transactions whereby the majority of the transacted products being in phase II.
I should of said FDA approval instead of phase 2. It is...
Add to My Watchlist
What is My Watchlist?
